SCHEDULE 13D

CUSIP No.

09060U606

1

Name of reporting person

Daly Joseph Patrick

2

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

3

SEC use only

4

Source of funds (See Instructions)

PF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

6

Citizenship or place of organization

OHIO

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power
8	Shared Voting Power
9	Sole Dispositive Power
10	Shared Dispositive Power

11

Aggregate amount beneficially owned by each reporting person

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

13

Percent of class represented by amount in Row (11)

14

Type of Reporting Person (See Instructions)

SCHEDULE 13D

Item 1.

Security and Issuer

(a)

Title of Class of Securities:

Common Stock

(b)

Name of Issuer:

BioCardia, Inc.

(c)

Address of Issuer's Principal Executive Offices:

7660 COLDSTREAM DR, CINCINNATI, OHIO , 45255-3932.

Item 2.

Identity and Background

(a)

Joseph P. Daly

(b)

497 Circle Freeway Cincinnati, OH 45246

(c)

Owner, Essig Research Inc.

(d)

No

(e)

No

(f)

USA

Item 3.

Source and Amount of Funds or Other Consideration

N/A

Item 4.

Purpose of Transaction

N/A

Item 5.

Interest in Securities of the Issuer

(a)

N/A

(b)

N/A

(c)

N/A

(d)

N/A

(e)

05/13/2025

Item 6.

Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer

N/A

Item 7.

Material to be Filed as Exhibits.

N/A

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Daly Joseph Patrick

Signature:	Joseph P. Daly
Name/Title:	Joseph P. Daly
Date:	05/21/2025